12:00 AM
 | 
Jan 07, 2013
 |  BC Week In Review  |  Company News  |  Deals

Bio-Rad Laboratories, Lamprogen Inc. deal

On Dec. 20, 2012, Bio-Rad said Lamprogen granted Bio-Rad exclusive rights to commercialize a class of bright, stable, non-toxic fluorescent particles for use in...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >